Reinventing Bioinnovation

    loading  Checking for direct PDF access through Ovid


The landscape for bioinnovation is undergoing a seismic shift as drug developers, regulators, academic institutions, and government research organizations adapt to the formidable challenge of bringing new medicines to market. The inability to translate current advances in the scientific understanding of disease into new therapeutics is forcing all sectors to replace traditional drug development paradigms with newer and more efficient models. This issue ofClinical Pharmacology & Therapeuticsexplores these changes to the bioinnovation ecosystem.

Related Topics

    loading  Loading Related Articles